📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design. (2016)

First Author: Von Delft A

Attributed to: Immunity in the face of diversity and the development of novel potent HCV vaccines funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/gutjnl-2014-308724

PubMed Identifier: 26092843

Publication URI: http://europepmc.org/abstract/MED/26092843

Type: Journal Article/Review

Volume: 65

Parent Publication: Gut

Issue: 1

ISSN: 0017-5749